PL366576A1 - Formy polimorficzne chlorowodorku feksofenadyny - Google Patents
Formy polimorficzne chlorowodorku feksofenadynyInfo
- Publication number
- PL366576A1 PL366576A1 PL02366576A PL36657602A PL366576A1 PL 366576 A1 PL366576 A1 PL 366576A1 PL 02366576 A PL02366576 A PL 02366576A PL 36657602 A PL36657602 A PL 36657602A PL 366576 A1 PL366576 A1 PL 366576A1
- Authority
- PL
- Poland
- Prior art keywords
- polymorphs
- fexofenadine hydrochloride
- fexofenadine
- hydrochloride
- Prior art date
Links
- RRJFVPUCXDGFJB-UHFFFAOYSA-N Fexofenadine hydrochloride Chemical compound Cl.C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RRJFVPUCXDGFJB-UHFFFAOYSA-N 0.000 title 1
- 229960000354 fexofenadine hydrochloride Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28252101P | 2001-04-09 | 2001-04-09 | |
US30775201P | 2001-07-25 | 2001-07-25 | |
US31439601P | 2001-08-23 | 2001-08-23 | |
US33693001P | 2001-11-08 | 2001-11-08 | |
US33904101P | 2001-12-07 | 2001-12-07 | |
US34411401P | 2001-12-28 | 2001-12-28 | |
US36178002P | 2002-03-04 | 2002-03-04 | |
US36348202P | 2002-03-11 | 2002-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL366576A1 true PL366576A1 (pl) | 2005-02-07 |
Family
ID=27575329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL02366576A PL366576A1 (pl) | 2001-04-09 | 2002-04-08 | Formy polimorficzne chlorowodorku feksofenadyny |
Country Status (13)
Country | Link |
---|---|
US (3) | US20020177608A1 (pl) |
EP (1) | EP1392303A4 (pl) |
KR (1) | KR20040012747A (pl) |
AU (1) | AU2002305162A1 (pl) |
CA (1) | CA2444456A1 (pl) |
CZ (1) | CZ20033019A3 (pl) |
HR (1) | HRP20030900A2 (pl) |
HU (1) | HUP0400299A2 (pl) |
IL (1) | IL158334A0 (pl) |
MX (1) | MXPA03009259A (pl) |
PL (1) | PL366576A1 (pl) |
SK (1) | SK13822003A3 (pl) |
WO (1) | WO2002080857A2 (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9605613A (es) * | 1994-05-18 | 1998-05-31 | Hoechst Marion Roussel Inc | Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos. |
US7700779B2 (en) | 2001-06-18 | 2010-04-20 | Dr. Reddy's Laboratories Limited | Crystalline forms of fexofenadine and its hydrochloride |
DE60220953T2 (de) * | 2002-04-04 | 2008-02-28 | Dr. Reddy's Laboratories Ltd. | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
AU2003248657A1 (en) * | 2002-06-10 | 2003-12-22 | Teva Pharmaceutical Industries Ltd. | Polymorphic form xvi of fexofenadine hydrochloride |
GB0319935D0 (en) * | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
JP2007532687A (ja) * | 2004-04-26 | 2007-11-15 | テバ ファーマシューティカル インダストリーズ リミティド | フェキソフェナジン塩酸塩の結晶形およびその製造方法 |
JP2008514641A (ja) * | 2004-09-28 | 2008-05-08 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶形フェキソフェナジン、およびその調製方法 |
WO2007052310A2 (en) * | 2005-11-03 | 2007-05-10 | Morepen Laboratories Limited | Polymorphs of fexofenadine hydrochloride and process for their preparation |
CA2658170A1 (en) * | 2006-07-11 | 2008-01-17 | Mutual Pharmaceutical Company, Inc. | Controlled-release formulations |
EP2105134A1 (en) | 2008-03-24 | 2009-09-30 | Ranbaxy Laboratories Limited | Stable amorphous fexofenadine hydrochloride |
WO2009136412A2 (en) * | 2008-04-25 | 2009-11-12 | Matrix Laboratories Limited | PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF |
US20100183717A1 (en) * | 2009-01-16 | 2010-07-22 | Kristin Arnold | Controlled-release formulations |
WO2011158262A1 (en) * | 2010-06-15 | 2011-12-22 | Chemelectiva S.R.L. | Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation |
PE20160945A1 (es) | 2013-11-15 | 2016-09-26 | Akebia Therapeutics Inc | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acetico, composiciones, y usos de las mismas |
CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4285957A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof |
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
JPS61501205A (ja) * | 1984-02-15 | 1986-06-19 | シェリング・コ−ポレ−ション | 8↓−クロル↓−6,11↓−ジヒドロ↓−11↓−(4↓−ピペリジリデン)↓−5H↓−ベンゾ〔5,6〕シクロヘプタ〔1,2−b〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物 |
SE8403179D0 (sv) * | 1984-06-13 | 1984-06-13 | Haessle Ab | New compounds |
US4929605A (en) * | 1987-10-07 | 1990-05-29 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol derivatives |
US5631375A (en) * | 1992-04-10 | 1997-05-20 | Merrell Pharmaceuticals, Inc. | Process for piperidine derivatives |
AU671822B2 (en) * | 1992-04-10 | 1996-09-12 | Aventisub Ii Inc. | 4-diphenylmethyl piperidine derivatives and process for their preparation |
JPH07506828A (ja) * | 1992-05-11 | 1995-07-27 | メレルダウファーマス−ティカルズ インコーポレイテッド | 肝臓が損われた患者での抗ヒスタミン剤としてのターフェナジン誘導体の用途 |
DE69334145T2 (de) * | 1992-08-03 | 2008-01-24 | Sepracor Inc., Marlborough | Terfenadincarboxylat und die Behandlung von Hautreizung |
US5654433A (en) * | 1993-01-26 | 1997-08-05 | Merrell Pharmaceuticals Inc. | Process for piperidine derivatives |
PT1026147E (pt) * | 1993-06-24 | 2004-04-30 | Albany Molecular Res Inc | Compostos uteis como intermediarios na producao de derivados de piperidina |
WO1995000480A1 (en) * | 1993-06-25 | 1995-01-05 | Merrell Pharmaceuticals Inc. | Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
US6147216A (en) * | 1993-06-25 | 2000-11-14 | Merrell Pharmaceuticals Inc. | Intermediates useful for the preparation of antihistaminic piperidine derivatives |
MX9605613A (es) * | 1994-05-18 | 1998-05-31 | Hoechst Marion Roussel Inc | Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos. |
EP0812195B1 (en) * | 1995-02-28 | 2002-10-30 | Aventis Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol compounds |
US6201124B1 (en) * | 1995-12-21 | 2001-03-13 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
US5925761A (en) * | 1997-02-04 | 1999-07-20 | Sepracor Inc. | Synthesis of terfenadine and derivatives |
DE59810863D1 (de) * | 1997-03-11 | 2004-04-08 | Aventis Pharma Inc | Verfahren zur Herstellung von 4-(4-(4-(Hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha-dimenthylphenylessigsäure und phosphorylierter Derivate |
US6451815B1 (en) * | 1997-08-14 | 2002-09-17 | Aventis Pharmaceuticals Inc. | Method of enhancing bioavailability of fexofenadine and its derivatives |
PT998272E (pt) * | 1997-08-26 | 2003-09-30 | Aventis Pharma Inc | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol |
US5885912A (en) * | 1997-10-08 | 1999-03-23 | Bumbarger; Thomas H. | Protective multi-layered liquid retaining composite |
IN191492B (pl) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
US6613906B1 (en) * | 2000-06-06 | 2003-09-02 | Geneva Pharmaceuticals, Inc. | Crystal modification |
CA2436418A1 (en) * | 2001-01-30 | 2002-08-08 | Board Of Regents, The University Of Texas Systems | Process for production of nanoparticles and microparticles by spray freezing into liquid |
CH695216A5 (de) * | 2001-02-23 | 2006-01-31 | Cilag Ag | Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes. |
US20030021849A1 (en) * | 2001-04-09 | 2003-01-30 | Ben-Zion Dolitzky | Polymorphs of fexofenadine hydrochloride |
CA2646802A1 (en) * | 2001-06-18 | 2002-12-27 | Dr. Reddy's Laboratories Ltd. | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.alpha.-dimethylbenzene acetic acid and its hydrochloride |
PT1414453E (pt) * | 2001-07-31 | 2008-05-29 | Texcontor Ets | Polimorfo de cloridrato de fexofenadina |
DE60220953T2 (de) * | 2002-04-04 | 2008-02-28 | Dr. Reddy's Laboratories Ltd. | Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon |
AU2003248657A1 (en) * | 2002-06-10 | 2003-12-22 | Teva Pharmaceutical Industries Ltd. | Polymorphic form xvi of fexofenadine hydrochloride |
US20050065183A1 (en) * | 2003-07-31 | 2005-03-24 | Indranil Nandi | Fexofenadine composition and process for preparing |
US20050069590A1 (en) * | 2003-09-30 | 2005-03-31 | Buehler Gail K. | Stable suspensions for medicinal dosages |
EP1713757A2 (en) * | 2004-02-10 | 2006-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydroaminomethylation of olefins |
US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
-
2002
- 2002-04-08 US US10/118,807 patent/US20020177608A1/en not_active Abandoned
- 2002-04-08 IL IL15833402A patent/IL158334A0/xx unknown
- 2002-04-08 CZ CZ20033019A patent/CZ20033019A3/cs unknown
- 2002-04-08 HU HU0400299A patent/HUP0400299A2/hu unknown
- 2002-04-08 SK SK1382-2003A patent/SK13822003A3/sk unknown
- 2002-04-08 KR KR10-2003-7013226A patent/KR20040012747A/ko not_active Application Discontinuation
- 2002-04-08 WO PCT/US2002/011251 patent/WO2002080857A2/en not_active Application Discontinuation
- 2002-04-08 MX MXPA03009259A patent/MXPA03009259A/es not_active Application Discontinuation
- 2002-04-08 EP EP02733966A patent/EP1392303A4/en not_active Withdrawn
- 2002-04-08 AU AU2002305162A patent/AU2002305162A1/en not_active Abandoned
- 2002-04-08 PL PL02366576A patent/PL366576A1/pl unknown
- 2002-04-08 CA CA002444456A patent/CA2444456A1/en not_active Abandoned
-
2003
- 2003-09-12 US US10/661,259 patent/US20040058955A1/en not_active Abandoned
- 2003-11-07 HR HR20030900A patent/HRP20030900A2/xx not_active Application Discontinuation
-
2008
- 2008-09-09 US US12/207,372 patent/US20090149497A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2444456A1 (en) | 2002-10-17 |
US20040058955A1 (en) | 2004-03-25 |
WO2002080857A3 (en) | 2003-12-18 |
IL158334A0 (en) | 2004-05-12 |
SK13822003A3 (sk) | 2004-09-08 |
AU2002305162A1 (en) | 2002-10-21 |
KR20040012747A (ko) | 2004-02-11 |
EP1392303A2 (en) | 2004-03-03 |
EP1392303A4 (en) | 2005-01-26 |
MXPA03009259A (es) | 2004-06-03 |
WO2002080857A2 (en) | 2002-10-17 |
WO2002080857A8 (en) | 2004-05-27 |
CZ20033019A3 (cs) | 2004-07-14 |
US20090149497A1 (en) | 2009-06-11 |
HUP0400299A2 (en) | 2007-08-28 |
HRP20030900A2 (en) | 2005-08-31 |
US20020177608A1 (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL159426A0 (en) | Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride | |
HU0200438D0 (en) | Novel clopidogrel hydrochloride polymorphs | |
HUP0400299A2 (en) | Polymorphs of fexofenadine hydrochloride | |
HUP0500753A3 (en) | Crystalline forms of valacyclovir hydrochloride | |
EP1562900A4 (en) | POLYMORPH OF BICIFADINHYDROCHLORIDE | |
IL165689A0 (en) | Polymorphic form XVI of fexofenadine hydrochloride | |
AU2002357701A1 (en) | Polymorphs of fexofenadine base | |
PL374799A1 (pl) | Nowa sól i odmiany polimorficzne hemifumaranu desloratadyny | |
IL161521A0 (en) | N-formyl derivatives of paroxetine | |
IL161816A0 (en) | Polymorphs of fexofenadine base | |
TW493722U (en) | Improved structure of lampwick | |
IL160924A0 (en) | Stabilization of amrubicin hydrochloride | |
TW532183U (en) | Improved structure for elevation of treadmill | |
IL163593A0 (en) | Preparation of paroxetine involving novel intermediates | |
TW496118U (en) | Improved structure of dummy fish-bait | |
AU2002355679A1 (en) | Fexofenadine polymorph | |
AU2002347399A1 (en) | Venlafaxine hydrochloride polymorphs | |
HU0104370D0 (en) | Honeyed schnaps of oerseg | |
TW488312U (en) | Improved structure of handcar | |
TW589936U (en) | Improved structure of aqua-aerator | |
TW552878U (en) | Improved structure of hairclip | |
TW567750U (en) | Improved structure of panty-hose | |
TW499920U (en) | Improved structure of hoverbed | |
TW552879U (en) | Improved structure of hairclip | |
PL346451A1 (en) | Novel derivative of l-homophenylamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |